3,478
Views
5
CrossRef citations to date
0
Altmetric
Full Critical Review

Biodegradable Mg-based alloys: biological implications and restorative opportunities

, , , , , , , , ORCID Icon, , , , & ORCID Icon show all
Pages 365-403 | Received 23 Oct 2020, Accepted 07 May 2022, Published online: 16 Jun 2022

Figures & data

Figure 1. Schematic of the degradation environment of a Mg-based alloy screw in bone tissue.

Figure 1. Schematic of the degradation environment of a Mg-based alloy screw in bone tissue.

Figure 2. Schematic of the biomechanical environment of a stent in a blood vessel.

Figure 2. Schematic of the biomechanical environment of a stent in a blood vessel.

Table 1. Summary of biological processes at cellular and tissue levels that can be mediated by the degradation products of Mg-based alloys.

Figure 3. Representative images showing the formation of porosity in the bone near Mg-based alloy implants. (a) Ex vivo micro-CT 2-D images of bone implant complexes after implantation of LAE442 alloy in NZW rabbit tibia for 12 months [Citation21]. T: tibia; F: fibula; E: endosteal bone formation; C: cavities. (b) Micro-CT images of rat femora implanted with pure Mg or SS rod for 2 weeks [Citation20]. (c) Tartrate-resistant acid phosphatase (TRAP)-stained histological slices of mouse femora cortical bone on the 14th days after implantation with Mg or Ti rods.

Figure 3. Representative images showing the formation of porosity in the bone near Mg-based alloy implants. (a) Ex vivo micro-CT 2-D images of bone implant complexes after implantation of LAE442 alloy in NZW rabbit tibia for 12 months [Citation21]. T: tibia; F: fibula; E: endosteal bone formation; C: cavities. (b) Micro-CT images of rat femora implanted with pure Mg or SS rod for 2 weeks [Citation20]. (c) Tartrate-resistant acid phosphatase (TRAP)-stained histological slices of mouse femora cortical bone on the 14th days after implantation with Mg or Ti rods.

Figure 4. Examples of Mg-alloy-based bone-fixation implants. (a) Mg plate and screws for fractured ulna fixation. μCT and toluidine-blue staining of cortical bone after 8 and 16 weeks [Citation376]. (b) Pure-Mg and PLLA screws for femoral intracondylar fracture fixation. μCT scanning of rabbit femur with screws after 4 weeks (red arrows: fracture gap) [Citation277]; (c) SrHPO4-coated JDBM (a Mg–Nd–Zn–Zr alloy) IMNs. Undecalcified sections with Von Gieson staining and μCT 3D reconstruction of rat femurs with IMNs after 8 weeks (red boxes: fracture gap region) [Citation239]; (d) Pure-Mg screw for goat femoral neck fracture fixation, and preoperative and 48-week postoperative μCT 3D reconstruction [Citation380]; (e) Ti/Mg hybrid plate screw system for the fractured tibia fixation (red or blue arrows: Mg screw with PLA coating) [Citation278]; (f) SS/Mg hybrid IMN made by inserting a Mg rod into a hollow stainless steel needle with drilled holes [Citation20].

Figure 4. Examples of Mg-alloy-based bone-fixation implants. (a) Mg plate and screws for fractured ulna fixation. μCT and toluidine-blue staining of cortical bone after 8 and 16 weeks [Citation376]. (b) Pure-Mg and PLLA screws for femoral intracondylar fracture fixation. μCT scanning of rabbit femur with screws after 4 weeks (red arrows: fracture gap) [Citation277]; (c) SrHPO4-coated JDBM (a Mg–Nd–Zn–Zr alloy) IMNs. Undecalcified sections with Von Gieson staining and μCT 3D reconstruction of rat femurs with IMNs after 8 weeks (red boxes: fracture gap region) [Citation239]; (d) Pure-Mg screw for goat femoral neck fracture fixation, and preoperative and 48-week postoperative μCT 3D reconstruction [Citation380]; (e) Ti/Mg hybrid plate screw system for the fractured tibia fixation (red or blue arrows: Mg screw with PLA coating) [Citation278]; (f) SS/Mg hybrid IMN made by inserting a Mg rod into a hollow stainless steel needle with drilled holes [Citation20].

Figure 5. Spinal cage made of Mg-based alloys. (a) A hybrid cage consisting of the AZ31 alloy and PCL [Citation391]. Left: AZ31 alloy skeleton of the cage, Right: Cage after infiltration and covering with the PCL; (b) A micro-arc oxidation (MAO)-coated Mg–Zn alloy cage [Citation392]; (c) An MAO-coated AZ31 alloy cage [Citation393].

Figure 5. Spinal cage made of Mg-based alloys. (a) A hybrid cage consisting of the AZ31 alloy and PCL [Citation391]. Left: AZ31 alloy skeleton of the cage, Right: Cage after infiltration and covering with the PCL; (b) A micro-arc oxidation (MAO)-coated Mg–Zn alloy cage [Citation392]; (c) An MAO-coated AZ31 alloy cage [Citation393].

Figure 6. Animal studies and clinical case analysis of Mg-based alloy vascular stents. (a) Haematoxylin-eosin (H&E) staining images and μCT 3D reconstructed images of JDBM (a Mg–Nd–Zn–Zr alloy) stents in rabbit common carotid artery at different time points [Citation407]; (b) Optical coherence tomography 2D images of Magmaris® WE43-alloy-based stent in human coronary artery demonstrated excellent strut apposition with some struts covering the side branch post-implantation; no visible strut remnants exist; and struts initially covering the side branch being resorbed after 12 months [Citation6].

Figure 6. Animal studies and clinical case analysis of Mg-based alloy vascular stents. (a) Haematoxylin-eosin (H&E) staining images and μCT 3D reconstructed images of JDBM (a Mg–Nd–Zn–Zr alloy) stents in rabbit common carotid artery at different time points [Citation407]; (b) Optical coherence tomography 2D images of Magmaris® WE43-alloy-based stent in human coronary artery demonstrated excellent strut apposition with some struts covering the side branch post-implantation; no visible strut remnants exist; and struts initially covering the side branch being resorbed after 12 months [Citation6].

Figure 7. Animal studies of Mg-based surgical instruments for hemostasis and anastomosis. (a) Mg-Zn-Ca-Y alloy clip occluded the proximal and telecentric stump of rat carotid blood vessels (i), and cuts the blood vessel from the middle of the two hemostatic clips (ii) [Citation420]; (b) Pure-Mg staples for anastomose small intestine (i), and no bleeding and intestinal fluid exudation after anastomosis (ii) [Citation421]; (c) Mg–Zn–Sr intestinal anastomosis ring (i) and surgical procedure of intestinal anastomosis(ii) [Citation422].

Figure 7. Animal studies of Mg-based surgical instruments for hemostasis and anastomosis. (a) Mg-Zn-Ca-Y alloy clip occluded the proximal and telecentric stump of rat carotid blood vessels (i), and cuts the blood vessel from the middle of the two hemostatic clips (ii) [Citation420]; (b) Pure-Mg staples for anastomose small intestine (i), and no bleeding and intestinal fluid exudation after anastomosis (ii) [Citation421]; (c) Mg–Zn–Sr intestinal anastomosis ring (i) and surgical procedure of intestinal anastomosis(ii) [Citation422].

Figure 8. Mg-based tissue engineering scaffolds for bone defect repair. (a) Digital and scanning electron microscope (SEM) images of Mg/JDBM-MgF2 scaffold without and with brushite (DCPD) coating. μCT images showing the new bone and vascular formation in the defect area after 4 and 8 weeks (red or white line: bone defect area) [Citation431]; (b) SEM and 2D μCT images of Mg scaffolds; 2D μCT images (red arrows: new bone) and alizarin red S and calcein sequential labels of new bone after 16 weeks [Citation167]; (c) MAO-coated tubular Mg–Zn–Ca scaffold for ulna bone defect repair and X-ray observation after 2, 4, 8 and 12 weeks [Citation433]; (d) A biomimetic-porous Mg material coated with HA/(PEI-SiO2) hybrid layer for femoropatellar defect repair, and a μCT image of femoropatellar bone and the porous Mg [Citation435]; (e) A biomimetic-Mg scaffold for humerus defect repair and X-ray images at various periods [Citation436]; (f) μCT and SEM images of porous alginate/gelatin hydrogel with Mg powder. μCT images, sequential fluorescence staining, H&E staining, and OSX/CD31 immunofluorescence staining of bone formation in defects after 3 weeks, and μCT images of 3D vasculature in defects after 2 weeks, in Blank, Mg free (−Mg) and Mg containing (+Mg) hydrogel groups [Citation437].

Figure 8. Mg-based tissue engineering scaffolds for bone defect repair. (a) Digital and scanning electron microscope (SEM) images of Mg/JDBM-MgF2 scaffold without and with brushite (DCPD) coating. μCT images showing the new bone and vascular formation in the defect area after 4 and 8 weeks (red or white line: bone defect area) [Citation431]; (b) SEM and 2D μCT images of Mg scaffolds; 2D μCT images (red arrows: new bone) and alizarin red S and calcein sequential labels of new bone after 16 weeks [Citation167]; (c) MAO-coated tubular Mg–Zn–Ca scaffold for ulna bone defect repair and X-ray observation after 2, 4, 8 and 12 weeks [Citation433]; (d) A biomimetic-porous Mg material coated with HA/(PEI-SiO2) hybrid layer for femoropatellar defect repair, and a μCT image of femoropatellar bone and the porous Mg [Citation435]; (e) A biomimetic-Mg scaffold for humerus defect repair and X-ray images at various periods [Citation436]; (f) μCT and SEM images of porous alginate/gelatin hydrogel with Mg powder. μCT images, sequential fluorescence staining, H&E staining, and OSX/CD31 immunofluorescence staining of bone formation in defects after 3 weeks, and μCT images of 3D vasculature in defects after 2 weeks, in Blank, Mg free (−Mg) and Mg containing (+Mg) hydrogel groups [Citation437].